Johnson & Johnson topped the Bioethics International “Good Pharma Scorecard” for the second year in a row.

It’s important for the pharma industry to take a closer look at the benefits of going beyond the pill and leveraging technology to deliver better care resulting in better patient outcomes and potential savings to the overall health system.